Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust pharmacodynamic responses across a range of tolerated doses; NXP900 has an acceptable ...

The areas most likely to see an impact among medical equipment include medical imaging devices, diagnostic equipment, ...

Astellas Pharma Inc. (ALPMY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Tuesday, April 29, 2025. Let’s ...

A historic Black church in downtown Memphis that was the organizing point for Martin Luther King Jr.’s final campaign in 1968 caught fire early Monday morning and ...

Below are the key results presented at AACR for MaaT034: ...

As the U.S. government brandishes funding cuts, hospital and health system leaders have voiced concerns about the future of academic and clinical innovation workforce pipelines. In an April 16 email ...

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions ...

For FTSE 100 businesses navigating the shifting sands of Trump’s trade war, the uncertainty surrounding the tariffs has been ...

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

US drug tariffs may not hit branded prices hard, but generics and supply chains face disruption. Here's what pharma leaders ...